Does tocilizumab eliminate inflammation in GCA? A cohort study on repeated temporal artery biopsies

Background Vascular inflammation persists in temporal artery biopsy (TAB) of giant cell arteritis (GCA) patients even after prolonged glucocorticoid (GC) therapy. We aimed to evaluate the histological impact of adding tocilizumab (TCZ) to GCs.Methods We enrolled all consecutive GCA patients with an...

Whakaahuatanga katoa

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	Chiara Marvisi, Francesco Muratore, Carlo Salvarani, Pierluigi Macchioni, Pamela Mancuso, Luigi Boiardi, Stefania Croci, Paolo Giorgi Rossi, Alberto Cavazza, Annibale Versari, Rexhep Durmo, Caterina Ricordi, Martina Bonacini, Giuseppe Malchiodi
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	BMJ Publishing Group 2024-12-01
Rangatū:	RMD Open
Urunga tuihono:	https://rmdopen.bmj.com/content/10/4/e005132.full
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Does tocilizumab eliminate inflammation in GCA? A cohort study on repeated temporal artery biopsies

Ngā tūemi rite